Abstract
Proteins are considered magic molecules due to their enormous applications in the health sector. Over the past few decades, therapeutic proteins have emerged as a promising treatment option for various diseases, particularly cancer, cardiovascular disease, diabetes, and others. The formulation of protein-based therapies is a major area of research, however, a few factors still hinder the large-scale production of these therapeutic products, such as stability, heterogenicity, immunogenicity, high cost of production, etc. This review provides comprehensive information on various sources and production of therapeutic proteins. The review also summarizes the challenges currently faced by scientists while developing protein-based therapeutics, along with possible solutions. It can be concluded that these proteins can be used in combination with small molecular drugs to give synergistic benefits in the future.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adan Gökbulut A, Arslanoğlu A (2013) Purification and biochemical characterization of an extracellular lipase from psychrotolerant Pseudomonas fluorescens KE38. Turk J Biol 37:538–546. https://doi.org/10.3906/biy-1211-10
Ahmad I, Rubbab T, Deeba F, Naqvi SMS (2014a) Optimization of E. coli culture conditions for efficient DNA uptake by electroporation. Turk J Biol 38:568–573. https://doi.org/10.3906/biy-1311-60
Ahmad M, Hirz M, Pichler H, Schwab H (2014b) Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol 98:5301–5317. https://doi.org/10.1007/s00253-014-5732-5
Ahmed H, Elzahab HA, Alswiai G (2013) Purification of antioxidant protein isolated from Peganum harmala and its protective effect against CCl4 toxicity in rats. Turk J Biol. https://doi.org/10.3906/biy-1110-29
Akash MSH, Rehman K, Li N et al (2012a) Sustained delivery of IL-1Ra from Pluronic F127-based thermosensitive gel prolongs its therapeutic potentials. Pharm Res 29:3475–3485. https://doi.org/10.1007/s11095-012-0843-0
Akash MSH, Shen Q, Rehman K, Chen S (2012b) Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci 101:1647–1658. https://doi.org/10.1002/jps.23057
Al Shaer D, Al Musaimi O, Albericio F, De La Torre BG (2020) 2019 FDA TIDES (peptides and oligonucleotides) harvest. Pharmaceuticals 13:40. https://doi.org/10.3390/ph13030040
Albericio F, Kruger HG (2012) Therapeutic peptides. Future Med Chem 4:1527–1531. https://doi.org/10.4155/fmc.12.94
Aleem A, Akbar Samad AB, Vaqar S (2023) Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). In: StatPearls. StatPearls Publishing, Treasure Island
Amawi H, Abu Deiab GI, Aljabali A, AA et al (2020) COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics. Ther Deliv 11:245–268. https://doi.org/10.4155/tde-2020-0035
Amiri S, Adibzadeh S, Ghanbari S et al (2023) CRISPR-interceded CHO cell line development approaches. Biotech Bioeng 120:865–902. https://doi.org/10.1002/bit.28329
Aravindan R, Viruthagiri T, Seenivasan A, Subhagar S (2008) Microbial production and biomedical applications of lovastatin. Indian J Pharm Sci 70:701. https://doi.org/10.4103/0250-474X.49087
Aris P, Wei Y, Mohamadzadeh M, Xia X (2022) Griseofulvin: an updated overview of old and current knowledge. Molecules 27:7034. https://doi.org/10.3390/molecules27207034
Baeshen NA, Baeshen MN, Sheikh A et al (2014) Cell factories for insulin production. Microb Cell Fact 13:141. https://doi.org/10.1186/s12934-014-0141-0
Baeshen MN, Al-Hejin AM, Bora RS et al (2015) Production of biopharmaceuticals in E. coli: current scenario and future perspectives. J Microbiol Biotechnol 25:953–962. https://doi.org/10.4014/jmb.1412.12079
Baghban R, Farajnia S, Rajabibazl M et al (2019) Yeast expression systems: overview and recent advances. Mol Biotechnol 61:365–384. https://doi.org/10.1007/s12033-019-00164-8
Baghban R, Farajnia S, Ghasemi Y et al (2020) Mutational analysis of ocriplasmin to reduce proteolytic and autolytic activity in Pichia pastoris. Biol Proced Online 22:25. https://doi.org/10.1186/s12575-020-00138-0
Bailon P, Won C-Y (2009) PEG-modified biopharmaceuticals. Expert Opin Drug Deliv 6:1–16. https://doi.org/10.1517/17425240802650568
Balamurugan V, Reddy GR, Suryanarayana VV (2007) Pichia pastoris: a notable heterologous expression system for the production of foreign proteins—vaccines. Ind J Biotechnol 6:175–186
Balasubramanian S, Peery RB, Minshull J et al (2018) Generation of high expressing chinese hamster ovary cell pools using the leap-in transposon system. Biotechnol J 13:1700748. https://doi.org/10.1002/biot.201700748
Bandaranayake AD, Almo SC (2014) Recent advances in mammalian protein production. FEBS Lett 588:253–260. https://doi.org/10.1016/j.febslet.2013.11.035
Banerjee A, Ward V (2022) Production of recombinant and therapeutic proteins in microalgae. Curr Opin Biotechnol 78:102784. https://doi.org/10.1016/j.copbio.2022.102784
Barahimipour R, Neupert J, Bock R (2016) Efficient expression of nuclear transgenes in the green alga Chlamydomonas: synthesis of an HIV antigen and development of a new selectable marker. Plant Mol Biol 90:403–418. https://doi.org/10.1007/s11103-015-0425-8
Barbosa MJ, Janssen M, Südfeld C et al (2023) Hypes, hopes, and the way forward for microalgal biotechnology. Trends Biotechnol 41:452–471. https://doi.org/10.1016/j.tibtech.2022.12.017
Barman P, Joshi S, Sharma S et al (2023) Strategic approaches to improvise peptide drugs as next generation therapeutics. Int J Pept Res Ther 29:61. https://doi.org/10.1007/s10989-023-10524-3
Bayry J, Aimanianda V, Guijarro JI et al (2012) Hydrophobins—unique fungal proteins. PLoS Pathog 8:e1002700. https://doi.org/10.1371/journal.ppat.1002700
Belén LH, Beltrán Lissabet JF, De Oliveira R-Y et al (2020) Immunogenicity assessment of fungal l-asparaginases: an in silico approach. SN Appl Sci 2:222. https://doi.org/10.1007/s42452-020-2021-z
Berndt AJ, Smalley TN, Ren B et al (2021) Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii. PLoS ONE 16:e0257089. https://doi.org/10.1371/journal.pone.0257089
Bertolini LR, Meade H, Lazzarotto CR et al (2016) The transgenic animal platform for biopharmaceutical production. Transgenic Res 25:329–343. https://doi.org/10.1007/s11248-016-9933-9
Bhatia S, Singh A, Batra N, Singh J (2020) Microbial production and biotechnological applications of α-galactosidase. Int J Biol Macromol 150:1294–1313. https://doi.org/10.1016/j.ijbiomac.2019.10.140
Bhuvanesh S, Arunkumar C, Kaliraj P, Ramalingam S (2010) Production and single-step purification of Brugia malayi abundant larval transcript (ALT-2) using hydrophobic interaction chromatography. J Ind Microbiol Biotechnol 37:1053–1059. https://doi.org/10.1007/s10295-010-0753-2
Bill RM (2015) Recombinant protein subunit vaccine synthesis in microbes: a role for yeast? J Pharm Pharmacol 67:319–328. https://doi.org/10.1111/jphp.12353
Borovsky D, Sterner A, Powell CA (2016) Cloning and expressing trypsin modulating oostatic factor in Chlorella desiccata to control mosquito larvae: expression of TMOF in Chlorella desiccata to control mosquito larvae. Arch Insect Biochem Physiol 91:17–36. https://doi.org/10.1002/arch.21306
Bozzacco L, Yu H, Zebroski HA et al (2011) Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res 10:5016–5030. https://doi.org/10.1021/pr200503g
Buchwald H, Dorman RB, Rasmus NF et al (2014) Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition. Surg Obes Related Dis 10:780–786. https://doi.org/10.1016/j.soard.2014.01.032
Burnett MJB, Burnett AC (2020) Therapeutic recombinant protein production in plants: challenges and opportunities. Plants People Planet 2:121–132. https://doi.org/10.1002/ppp3.10073
Buyel JF (2018) Plants as sources of natural and recombinant anti-cancer agents. Biotechnol Adv 36:506–520. https://doi.org/10.1016/j.biotechadv.2018.02.002
Buyel JF, Twyman RM, Fischer R (2017) Very-large-scale production of antibodies in plants: the biologization of manufacturing. Biotechnol Adv 35:458–465. https://doi.org/10.1016/j.biotechadv.2017.03.011
Caetano KAA, Del-Rios NHA, Pinheiro RS et al (2017) Low immunogenicity of recombinant hepatitis b vaccine derived from Hansenula polymorpha in adults aged over 40 years. Am J Trop Med Hyg 96:118–121. https://doi.org/10.4269/ajtmh.16-0475
Cai D, Wang H, He P et al (2017) A novel strategy to improve protein secretion via overexpression of the SppA signal peptide peptidase in Bacillus licheniformis. Microb Cell Fact 16:70. https://doi.org/10.1186/s12934-017-0688-7
Caminschi I, Maraskovsky E, Heath WR (2012) Targeting dendritic cells in vivo for cancer therapy. Front Immunol 3:13. https://doi.org/10.3389/fimmu.2012.00013
Cammalleri L, Malaguarnera M (2007) Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci. https://doi.org/10.7150/ijms.4.83
Campos-Neto A, Rodrigues-Júnior V, Pedral-Sampaio DB et al (2001) Evaluation of DPPD, a single recombinant Mycobacterium tuberculosis protein as an alternative antigen for the Mantoux test. Tuberculosis 81:353–358. https://doi.org/10.1054/tube.2001.0311
Cao J, De La Fuente-Nunez C, Ou RW et al (2018) Yeast-based synthetic biology platform for antimicrobial peptide production. ACS Synth Biol 7:896–902. https://doi.org/10.1021/acssynbio.7b00396
Celińska E, Białas W, Borkowska M, Grajek W (2015) Cloning, expression, and purification of insect (Sitophilus oryzae) alpha-amylase, able to digest granular starch, in Yarrowia lipolytica host. Appl Microbiol Biotechnol 99:2727–2739. https://doi.org/10.1007/s00253-014-6314-2
Celińska E, Borkowska M, Białas W (2016) Evaluation of heterologous α -amylase production in two expression platforms dedicated for Yarrowia lipolytica : commercial Po1g-pYLSC ( php4d ) and custom-made A18-pYLTEF ( pTEF ): comparison of two Yarrowia -based systems in expression of α -amylase. Yeast 33:165–181. https://doi.org/10.1002/yea.3149
Celińska E, Borkowska M, Białas W (2017) Enhanced production of insect raw-starch-digesting alpha-amylase accompanied by high erythritol synthesis in recombinant Yarrowia lipolytica fed-batch cultures at high-cell-densities. Process Biochem 52:78–85. https://doi.org/10.1016/j.procbio.2016.10.022
Chaudet MM, Allen J-L, Rose DR (2012) Expression and purification of two Family GH31 α-glucosidases from Bacteroides thetaiotaomicron. Protein Expr Purif 86:135–141. https://doi.org/10.1016/j.pep.2012.09.009
Chen L, Yang X, Luo D, Yu W (2016) Efficient production of a bioactive bevacizumab monoclonal antibody using the 2a self-cleavage peptide in transgenic rice callus. Front Plant Sci. https://doi.org/10.3389/fpls.2016.01156
Chen B-M, Cheng T-L, Roffler SR (2021) Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies. ACS Nano 15:14022–14048. https://doi.org/10.1021/acsnano.1c05922
Chen Z, Wang X, Chen X et al (2023) Accelerating therapeutic protein design with computational approaches toward the clinical stage. Comput Struct Biotechnol J 21:2909–2926. https://doi.org/10.1016/j.csbj.2023.04.027
Chennamsetty N, Voynov V, Kayser V et al (2009) Design of therapeutic proteins with enhanced stability. Proc Natl Acad Sci USA 106:11937–11942. https://doi.org/10.1073/pnas.0904191106
Choi T-J, Geletu TT (2018) High level expression and purification of recombinant flounder growth hormone in E. coli. J Genet Eng Biotechnol 16:347–355. https://doi.org/10.1016/j.jgeb.2018.03.006
Chung M-E, Yeh I-H, Sung L-Y et al (2017) Enhanced integration of large DNA into E. coli chromosome by CRISPR/Cas9: CRISPR/Cas9 for bacterial genome engineering. Biotechnol Bioeng 114:172–183. https://doi.org/10.1002/bit.26056
Cizeau J, Grenkow DM, Brown JG et al (2009) Engineering and biological characterization of VB6-845, an anti-EpCAM immunotoxin containing a T-cell epitope-depleted variant of the plant toxin bouganin. J Immunother 32:574–584. https://doi.org/10.1097/CJI.0b013e3181a6981c
Clausen H, Wandall HH, DeLisa MP, Stanley P, Schnaar RL (2022) Glycosylation engineering. In: Essentials of glycobiology, 4th edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (PMID: 35536934)
Coler RN, Skeiky YAW, Ovendale PJ et al (2000) Cloning of a Mycobacterium tuberculosis gene encoding a purifed protein derivative protein that elicits strong tuberculosis-specific delayed-type hypersensitivity. J INFECT DIS 182:224–233. https://doi.org/10.1086/315677
Commault AS, Kaur Walia N, Fabris M et al (2020) Effect of biphasic temperature regime on therapeutic recombinant protein production in the green alga Chlamydomonas reinhardtii. Algal Res 50:101997. https://doi.org/10.1016/j.algal.2020.101997
Corwin HL, Gettinger A, Pearl RG et al (2002) Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA 288:2827. https://doi.org/10.1001/jama.288.22.2827
Craig TJ, Li HH, Riedl M et al (2015) Characterization of anaphylaxis after ecallantide treatment of hereditary angioedema attacks. J Allergy Clin Immunol In Pract 3:206-212.e4. https://doi.org/10.1016/j.jaip.2014.09.001
Craik DJ, Fairlie DP, Liras S, Price D (2013) The future of peptide-based drugs. Chem Biol Drug Des 81:136–147. https://doi.org/10.1111/cbdd.12055
Crosnier J, Jungers P, Couroucé A et al (1981) Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in French haemodialysis units: II, haemodialysis patients. The Lancet 317:797–800. https://doi.org/10.1016/S0140-6736(81)92679-9
Dana R (2018) Advances and innovations in recombinant protein expression technology. J Adv Pharm Educ Res 8:89
Darvishi F, Moradi M, Madzak C, Jolivalt C (2017) Production of laccase by recombinant Yarrowia lipolytica from molasses: bioprocess development using statistical modeling and increase productivity in shake-flask and bioreactor cultures. Appl Biochem Biotechnol 181:1228–1239. https://doi.org/10.1007/s12010-016-2280-8
Das S, Al-Toubah T, El-Haddad G, Strosberg J (2019) 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol 13:1023–1031. https://doi.org/10.1080/17474124.2019.1685381
De Jesus M, Wurm FM (2011) Manufacturing recombinant proteins in kg-ton quantities using animal cells in bioreactors. Eur J Pharm Biopharm 78:184–188. https://doi.org/10.1016/j.ejpb.2011.01.005
De Groot AS, McMurry J, Moise L (2008) Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. Curr Opin Pharmacol 8:620–626. https://doi.org/10.1016/j.coph.2008.08.002
Dehghani J, Adibkia K, Movafeghi A, et al (2020) Designing a new generation of expression toolkits for engineering of green microalgae; robust production of human interleukin-2. Bioimpacts 10:259–268. https://doi.org/10.34172/bi.2020.33
Demain AL, Vaishnav P (2009) Production of recombinant proteins by microbes and higher organisms. Biotechnol Adv 27:297–306. https://doi.org/10.1016/j.biotechadv.2009.01.008
Demurtas OC, Massa S, Ferrante P et al (2013) A chlamydomonas-derived human papillomavirus 16 E7 vaccine induces specific tumor protection. PLoS ONE 8:e61473. https://doi.org/10.1371/journal.pone.0061473
Deniz I, García-Vaquero M, Imamoglu E (2017) Trends in red biotechnology. Microalgae-based biofuels and bioproducts. Elsevier, New York, pp 429–460
Desai AK, Baloh CH, Sleasman JW et al (2020) Benefits of prophylactic short-course immune tolerance induction in patients with infantile pompe disease: demonstration of long-term safety and efficacy in an expanded cohort. Front Immunol 11:1727. https://doi.org/10.3389/fimmu.2020.01727
Dingman R, Balu-Iyer SV (2019) Immunogenicity of protein pharmaceuticals. J Pharm Sci 108:1637–1654. https://doi.org/10.1016/j.xphs.2018.12.014
Dirisala VR, Nair RR, Srirama K et al (2017) Recombinant pharmaceutical protein production in plants: unraveling the therapeutic potential of molecular pharming. Acta Physiol Plant 39:18. https://doi.org/10.1007/s11738-016-2315-3
Donini M, Marusic C (2019) Current state-of-the-art in plant-based antibody production systems. Biotechnol Lett 41:335–346. https://doi.org/10.1007/s10529-019-02651-z
Du T, Buenbrazo N, Kell L et al (2019) Cell Chem Biol 26:203-212.e5. https://doi.org/10.1016/j.chembiol.2018.10.017
Du L, Yang Y, Zhang X (2021) Neutralizing antibodies for the prevention and treatment of COVID-19. Cell Mol Immunol 18:2293–2306. https://doi.org/10.1038/s41423-021-00752-2
Duchin JS, Jereb JA, Nolan CM et al (1997) Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis. CLIN INFECT DIS 25:661–663. https://doi.org/10.1086/513771
Ducret A, Ackaert C, Bessa J, et al Assay format diversity in pre-clinical immunogenicity risk assessment: toward a possible harmonization of antigenicity assays. MAbs 14:1993522. https://doi.org/10.1080/19420862.2021.1993522
Dudek NL, Croft NP, Schittenhelm RB et al (2016) A systems approach to understand antigen presentation and the immune response. Methods Mol Biol 1394:189–209. https://doi.org/10.1007/978-1-4939-3341-9_14
Dumont J, Euwart D, Mei B et al (2016) Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives. Crit Rev Biotechnol 36:1110–1122. https://doi.org/10.3109/07388551.2015.1084266
Dyson MR (2016) Fundamentals of expression in mammalian cells. In: Vega MC (ed) Advanced technologies for protein complex production and characterization. Springer International Publishing, Cham, pp 217–224
Eichler-Stahlberg A, Weisheit W, Ruecker O, Heitzer M (2009) Strategies to facilitate transgene expression in Chlamydomonas reinhardtii. Planta 229:873–883. https://doi.org/10.1007/s00425-008-0879-x
El-Gendy MMAA, Awad MF, El-Shenawy FS, El-Bondkly AMA (2021) Production, purification, characterization, antioxidant and antiproliferative activities of extracellular L-asparaginase produced by Fusarium equiseti AHMF4. Saudi J Biol Sci 28:2540–2548. https://doi.org/10.1016/j.sjbs.2021.01.058
Eriksson BI, Wille-Jørgensen P, Kälebo P et al (1997) A comparison of recombinant hirudin with a low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 337:1329–1335. https://doi.org/10.1056/NEJM199711063371901
Evangelista L, Ravelli I, Bignotto A et al (2020) Ga-68 DOTA-peptides and F-18 FDG PET/CT in patients with neuroendocrine tumor: a review. Clin Imaging 67:113–116. https://doi.org/10.1016/j.clinimag.2020.05.035
Fahad S, Khan FA, Pandupuspitasari NS et al (2015) Recent developments in therapeutic protein expression technologies in plants. Biotechnol Lett 37:265–279. https://doi.org/10.1007/s10529-014-1699-7
Fan L, Kadura I, Krebs LE et al (2013) Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter. J Biotechnol 168:652–658. https://doi.org/10.1016/j.jbiotec.2013.08.021
Fernandes D, Pacheco LK, Sordi R et al (2021) Angiotensin II receptor type 1 blockade improves hyporesponsiveness to vasopressors in septic shock. Eur J Pharmacol 897:173953. https://doi.org/10.1016/j.ejphar.2021.173953
Ferrer-Miralles N, Domingo-Espín J, Corchero JL et al (2009) Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 8:17. https://doi.org/10.1186/1475-2859-8-17
Fink M, Cserjan-Puschmann M, Reinisch D, Striedner G (2021) High-throughput microbioreactor provides a capable tool for early stage bioprocess development. Sci Rep 11:2056. https://doi.org/10.1038/s41598-021-81633-6
Fischer R, Holland T, Sack M et al (2018) Glyco-engineering of plant-based expression systems. In: Rapp E, Reichl U (eds) Advances in glycobiotechnology. Springer International Publishing, Cham, pp 137–166
Fisher AC, Kamga M-H, Agarabi C et al (2019) The current scientific and regulatory landscape in advancing integrated continuous biopharmaceutical manufacturing. Trends Biotechnol 37:253–267. https://doi.org/10.1016/j.tibtech.2018.08.008
Fletcher E, Krivoruchko A, Nielsen J (2016) Industrial systems biology and its impact on synthetic biology of yeast cell factories: systems Biology and It’s Impact on Synthetic Biology. Biotechnol Bioeng 113:1164–1170. https://doi.org/10.1002/bit.25870
Fosgerau K, Hoffmann T (2015) Peptide therapeutics: current status and future directions. Drug Discovery Today 20:122–128. https://doi.org/10.1016/j.drudis.2014.10.003
Friedl C, Zitt E (2018) Role of etelcalcetide in the management of secondary hyperparathyroidism in hemodialysis patients: a review on current data and place in therapy. Drug Des Devel Ther 12:1589–1598. https://doi.org/10.2147/DDDT.S134103
Fu W, Chaiboonchoe A, Khraiwesh B et al (2016) Algal cell factories: approaches, applications, and potentials. Mar Drugs 14:225. https://doi.org/10.3390/md14120225
Fu W, Nelson DR, Mystikou A et al (2019) Advances in microalgal research and engineering development. Curr Opin Biotechnol 59:157–164. https://doi.org/10.1016/j.copbio.2019.05.013
Fukuda N, Senga Y, Honda S (2019) Anxa2—and Ctsd‐knockout CHO cell lines to diminish the risk of contamination with host cell proteins. Biotechnol Progr. https://doi.org/10.1002/btpr.2820
Furman BL (2017) Aspart Insulin. In: Reference module in biomedical sciences. Elsevier, New York
Gaidukov L, Wroblewska L, Teague B et al (2018) A multi-landing pad DNA integration platform for mammalian cell engineering. Nucleic Acids Res 46:4072–4086. https://doi.org/10.1093/nar/gky216
Gallo-Ramírez LE, Nikolay A, Genzel Y, Reichl U (2015) Bioreactor concepts for cell culture-based viral vaccine production. Expert Rev Vaccines 14:1181–1195. https://doi.org/10.1586/14760584.2015.1067144
Garcia JM, Biller BMK, Korbonits M et al (2021) Sensitivity and specificity of the macimorelin test for diagnosis of AGHD. Endocr Connect 10:76–83. https://doi.org/10.1530/EC-20-0491
Gasmi N, Lassoued R, Ayed A et al (2012) Production and characterization of human granulocyte–macrophage colony-stimulating factor (hGM-CSF) expressed in the oleaginous yeast Yarrowia lipolytica. Appl Microbiol Biotechnol 96:89–101. https://doi.org/10.1007/s00253-012-4141-x
Gellissen G, Melber K, Janowicz ZA et al (1992) Heterologous protein production in yeast. Antonie Van Leeuwenhoek 62:79–93. https://doi.org/10.1007/BF00584464
Ghaderi D, Taylor RE, Padler-Karavani V et al (2010) Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteins. Nat Biotechnol 28:863–867. https://doi.org/10.1038/nbt.1651
Ghaderi D, Zhang M, Hurtado-Ziola N, Varki A (2012) Production platforms for biotherapeutic glycoproteins. Occurrence, impact, and challenges of non-human sialylation. Biotechnol Genet Eng Rev 28:147–176. https://doi.org/10.5661/bger-28-147
Giordano C, Marchiò M, Timofeeva E, Biagini G (2014) Neuroactive peptides as putative mediators of antiepileptic ketogenic diets. Front Neurol 5:63. https://doi.org/10.3389/fneur.2014.00063
Gomaa EZ (2022) Production, characterization, and antitumor efficiency of l-glutaminase from halophilic bacteria. Bull Natl Res Cent 46:10. https://doi.org/10.1186/s42269-021-00693-w
Groell F, Jordan O, Borchard G (2018) In vitro models for immunogenicity prediction of therapeutic proteins. Eur J Pharm Biopharm 130:128–142. https://doi.org/10.1016/j.ejpb.2018.06.008
Gronemeyer P, Ditz R, Strube J (2014) Trends in upstream and downstream process development for antibody manufacturing. Bioengineering 1:188–212. https://doi.org/10.3390/bioengineering1040188
Gupta SK, Dangi AK, Smita M, et al (2019) Effectual bioprocess development for protein production. In: Applied microbiology and bioengineering. Elsevier, New York, pp 203–227
Gupta V, Sengupta M, Prakash J, Tripathy BC, Gupta V, Sengupta M, Prakash J, Tripathy BC (2017) Production of recombinant pharmaceutical proteins. Basic Appl Asp Biotechnol. https://doi.org/10.1007/978-981-10-0875-7_4
Gupta SK, Shukla P (2016) Advanced technologies for improved expression of recombinant proteins in bacteria: perspectives and applications. Crit Rev Biotechnol 36:1089–1098. https://doi.org/10.3109/07388551.2015.1084264
Gupta SK, Shukla P (2017a) Gene editing for cell engineering: trends and applications. Crit Rev Biotechnol 37:672–684. https://doi.org/10.1080/07388551.2016.1214557
Gupta SK, Shukla P (2017b) Sophisticated cloning, fermentation, and purification technologies for an enhanced therapeutic protein production: a review. Front Pharmacol 8:419. https://doi.org/10.3389/fphar.2017.00419
Hamid Akash MS, Rehman K, Chen S (2015) Natural and synthetic polymers as drug carriers for delivery of therapeutic proteins. Polym Rev 55:371–406. https://doi.org/10.1080/15583724.2014.995806
Hamuro L, Kijanka G, Kinderman F et al (2017) Perspectives on subcutaneous route of administration as an immunogenicity risk factor for therapeutic proteins. J Pharm Sci 106:2946–2954. https://doi.org/10.1016/j.xphs.2017.05.030
Hanke AT, Ottens M (2014) Purifying biopharmaceuticals: knowledge-based chromatographic process development. Trends Biotechnol 32:210–220. https://doi.org/10.1016/j.tibtech.2014.02.001
Haws R, Brady S, Davis E et al (2020) Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome. Diabetes Obes Metab 22:2133–2140. https://doi.org/10.1111/dom.14133
Hayashi K, Lee J-B, Atsumi K, et al (2019) In vitro and in vivo anti-herpes simplex virus activity of monogalactosyl diacylglyceride from Coccomyxa sp. KJ (IPOD FERM BP-22254), a green microalga. PLoS ONE 14:e0219305. https://doi.org/10.1371/journal.pone.0219305
Hefferon K (2017) Reconceptualizing cancer immunotherapy based on plant production systems. Future Sci OA 3:FSO217. https://doi.org/10.4155/fsoa-2017-0018
Heffner KM, Wang Q, Hizal DB et al (2018) Glycoengineering of mammalian expression systems on a cellular level. In: Rapp E, Reichl U (eds) Advances in glycobiotechnology. Springer International Publishing, Cham, pp 37–69
Hempel F, Lau J, Klingl A, Maier UG (2011) Algae as protein factories: expression of a human antibody and the respective antigen in the diatom Phaeodactylum tricornutum. PLoS ONE 6:e28424. https://doi.org/10.1371/journal.pone.0028424
Hempel F, Maurer M, Brockmann B et al (2017) From hybridomas to a robust microalgal-based production platform: molecular design of a diatom secreting monoclonal antibodies directed against the Marburg virus nucleoprotein. Microb Cell Fact 16:131. https://doi.org/10.1186/s12934-017-0745-2
Henninot A, Collins JC, Nuss JM (2018) The current state of peptide drug discovery: back to the future? J Med Chem 61:1382–1414. https://doi.org/10.1021/acs.jmedchem.7b00318
Hernández-Ramírez J, Wong-Arce A, González-Ortega O, Rosales-Mendoza S (2020) Expression in algae of a chimeric protein carrying several epitopes from tumor associated antigens. Int J Biol Macromol 147:46–52. https://doi.org/10.1016/j.ijbiomac.2019.12.250
Holtz BR, Berquist BR, Bennett LD et al (2015) Commercial-scale biotherapeutics manufacturing facility for plant-made pharmaceuticals. Plant Biotechnol J 13:1180–1190. https://doi.org/10.1111/pbi.12469
Hu J, Han J, Li H et al (2018) Human embryonic kidney 293 cells: a vehicle for biopharmaceutical manufacturing, structural biology, and electrophysiology. Cells Tissues Organs 205:1–8. https://doi.org/10.1159/000485501
Huang C, Ding T, Wang J et al (2019) CRISPR-Cas9-assisted native end-joining editing offers a simple strategy for efficient genetic engineering in Escherichia coli. Appl Microbiol Biotechnol 103:8497–8509. https://doi.org/10.1007/s00253-019-10104-w
Huertas MJ, Michán C (2019) Paving the way for the production of secretory proteins by yeast cell factories. Microb Biotechnol 12:1095–1096. https://doi.org/10.1111/1751-7915.13342
Hunter M, Yuan P, Vavilala D, Fox M (2019) Optimization of protein expression in mammalian cells. Curr Protoc Protein Sci 95:e77. https://doi.org/10.1002/cpps.77
Ingle KP, Singh A, Sahni T, et al (2023) Genome editing in the synthetic biology for sustainable production of biomolecules. In: Singh V, Show PL (eds) Biomanufacturing for sustainable production of biomolecules. Springer Nature Singapore, Singapore, pp 315–329
Jacquemart R, Vandersluis M, Zhao M et al (2016) A single-use strategy to enable manufacturing of affordable biologics. Comput Struct Biotechnol J 14:309–318. https://doi.org/10.1016/j.csbj.2016.06.007
Jarquín-Cordero M, Chávez MN, Centeno-Cerdas C et al (2020) Towards a biotechnological platform for the production of human pro-angiogenic growth factors in the green alga Chlamydomonas reinhardtii. Appl Microbiol Biotechnol 104:725–739. https://doi.org/10.1007/s00253-019-10267-6
Jawa V, Terry F, Gokemeijer J et al (2020) T-cell dependent immunogenicity of protein therapeutics pre-clinical assessment and mitigation-updated consensus and review 2020. Front Immunol 11:1301. https://doi.org/10.3389/fimmu.2020.01301
Jazayeri SH, Amiri-Yekta A, Bahrami S et al (2018) Vector and cell line engineering technologies toward recombinant protein expression in mammalian cell lines. Appl Biochem Biotechnol 185:986–1003. https://doi.org/10.1007/s12010-017-2689-8
Jesuraj SAV, Sarker MdMR, Ming LC et al (2017) Enhancement of the production of L-glutaminase, an anticancer enzyme, from Aeromonas veronii by adaptive and induced mutation techniques. PLoS ONE 12:e0181745. https://doi.org/10.1371/journal.pone.0181745
Ji X, Peng X, Long X et al (2022) Laccase-mediated functionalization of natamycin by gallic acids for the therapeutic effect on Aspergillus fumigatus keratitis. Eur J Pharmacol 926:175041. https://doi.org/10.1016/j.ejphar.2022.175041
Jiskoot W, Randolph TW, Volkin DB et al (2012) Protein instability and immunogenicity: roadblocks to clinical application of injectable protein delivery systems for sustained release. J Pharm Sci 101:946–954. https://doi.org/10.1002/jps.23018
Jiskoot W, Kijanka G, Randolph TW et al (2016) Mouse models for assessing protein immunogenicity: lessons and challenges. J Pharm Sci 105:1567–1575. https://doi.org/10.1016/j.xphs.2016.02.031
Jozala AF, Geraldes DC, Tundisi LL et al (2016) Biopharmaceuticals from microorganisms: from production to purification. Braz J Microbiol 47:51–63. https://doi.org/10.1016/j.bjm.2016.10.007
Justesen S, Harndahl M, Lamberth K et al (2009) Functional recombinant MHC class II molecules and high-throughput peptide-binding assays. Immunome Res 5:2. https://doi.org/10.1186/1745-7580-5-2
Juturu V, Wu JC (2018) Heterologous protein expression in Pichia pastoris : latest research progress and applications. ChemBioChem 19:7–21. https://doi.org/10.1002/cbic.201700460
Kaewput C, Vinjamuri S (2022) Role of combined 68Ga DOTA-peptides and 18F FDG PET/CT in the evaluation of gastroenteropancreatic neuroendocrine neoplasms. Diagnostics (Basel) 12:280. https://doi.org/10.3390/diagnostics12020280
Kamermans A, Verhoeven T, van het Hof B et al (2019) Setmelanotide, a novel, selective melanocortin receptor-4 agonist exerts anti-inflammatory actions in astrocytes and promotes an anti-inflammatory macrophage phenotype. Front Immunol 10:2312. https://doi.org/10.3389/fimmu.2019.02312
Kamionka M (2011) Engineering of therapeutic proteins production in Escherichia coli. curr pharm biotechnol 12:268–274. https://doi.org/10.2174/138920111794295693
Kasli IM, Thomas ORT, Overton TW (2019) Use of a design of experiments approach to optimise production of a recombinant antibody fragment in the periplasm of Escherichia coli: selection of signal peptide and optimal growth conditions. AMB Expr 9:5. https://doi.org/10.1186/s13568-018-0727-8
Katla S, Yoganand KNR, Hingane S et al (2019) Novel glycosylated human interferon alpha 2b expressed in glycoengineered Pichia pastoris and its biological activity: N-linked glycoengineering approach. Enzyme Microb Technol 128:49–58. https://doi.org/10.1016/j.enzmictec.2019.05.007
Kaye Y, Grundman O, Leu S et al (2015) Metabolic engineering toward enhanced LC-PUFA biosynthesis in Nannochloropsis oceanica : overexpression of endogenous Δ12 desaturase driven by stress-inducible promoter leads to enhanced deposition of polyunsaturated fatty acids in TAG. Algal Res 11:387–398. https://doi.org/10.1016/j.algal.2015.05.003
Kelley B (2009) Industrialization of mAb production technology: the bioprocessing industry at a crossroads. mAbs 1:443–452. https://doi.org/10.4161/mabs.1.5.9448
Kesavadev J, Murthy LS, Chaudhury T et al (2022) One-year safety and effectiveness of insulin degludec in patients with diabetes mellitus in routine clinical practice in India—TRUST (Tresiba real-world use study). Metabol Open 14:100184. https://doi.org/10.1016/j.metop.2022.100184
Khavari F, Saidijam M, Taheri M, Nouri F (2021) Microalgae: therapeutic potentials and applications. Mol Biol Rep 48:4757–4765. https://doi.org/10.1007/s11033-021-06422-w
Kiefer AM, Niemeyer J, Probst A et al (2022) Production and secretion of functional SARS-CoV-2 spike protein in Chlamydomonas reinhardtii. Front Plant Sci 13:988870. https://doi.org/10.3389/fpls.2022.988870
Kim H, Kim J-S (2014) A guide to genome engineering with programmable nucleases. Nat Rev Genet 15:321–334. https://doi.org/10.1038/nrg3686
Kim HJ, Kim H-J (2017) Yeast as an expression system for producing virus-like particles: what factors do we need to consider? Lett Appl Microbiol 64:111–123. https://doi.org/10.1111/lam.12695
Kim SH, Lee GM (2007a) Down-regulation of lactate dehydrogenase-A by siRNAs for reduced lactic acid formation of Chinese hamster ovary cells producing thrombopoietin. Appl Microbiol Biotechnol 74:152–159. https://doi.org/10.1007/s00253-006-0654-5
Kim SH, Lee GM (2007b) Functional expression of human pyruvate carboxylase for reduced lactic acid formation of Chinese hamster ovary cells (DG44). Appl Microbiol Biotechnol 76:659–665. https://doi.org/10.1007/s00253-007-1041-6
Kim H, Yoo SJ, Kang HA (2014) Yeast synthetic biology for the production of recombinant therapeutic proteins. FEMS Yeast Res. https://doi.org/10.1111/1567-1364.12195
Kim J, Lee S, Baek K, Jin E (2020) Site-specific gene knock-out and on-site heterologous gene overexpression in Chlamydomonas reinhardtii via a CRISPR-Cas9-mediated knock-in method. Front Plant Sci 11:306. https://doi.org/10.3389/fpls.2020.00306
Kimia Z, Hosseini SN, Ashraf Talesh SS et al (2019) A novel application of ion exchange chromatography in recombinant hepatitis B vaccine downstream processing: improving recombinant HBsAg homogeneity by removing associated aggregates. J Chromatogr B 1113:20–29. https://doi.org/10.1016/j.jchromb.2019.03.009
King EM, Mazor R, Çuburu N, Pastan I (2018) Low-dose methotrexate prevents primary and secondary humoral immune responses and induces immune tolerance to a recombinant immunotoxin. J Immunol 200:2038–2045. https://doi.org/10.4049/jimmunol.1701430
Kintzing JR, Filsinger Interrante MV, Cochran JR (2016) Emerging strategies for developing next-generation protein therapeutics for cancer treatment. Trends Pharmacol Sci 37:993–1008. https://doi.org/10.1016/j.tips.2016.10.005
Kishimoto TK, Ferrari JD, LaMothe RA et al (2016) Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles. Nat Nanotechnol 11:890–899. https://doi.org/10.1038/nnano.2016.135
Klein CA, Emde L, Kuijpers A, Sobetzko P (2019) MoCloFlex: a modular yet flexible cloning system. Front Bioeng Biotechnol 7:271. https://doi.org/10.3389/fbioe.2019.00271
Kol S, Ley D, Wulff T et al (2020) Multiplex secretome engineering enhances recombinant protein production and purity. Nat Commun 11:1908. https://doi.org/10.1038/s41467-020-15866-w
Kontermann RE (2011) Strategies for extended serum half-life of protein therapeutics. Curr Opin Biotechnol 22:868–876. https://doi.org/10.1016/j.copbio.2011.06.012
Kost TA, Kemp CW (2016) Fundamentals of baculovirus expression and applications. In: Vega MC (ed) Advanced technologies for protein complex production and characterization. Springer International Publishing, Cham, pp 187–197
Kota RK, Ambati RR, YVV AK et al (2018) Recent advances in probiotics as live biotherapeutics against gastrointestinal diseases. CPD 24:3162–3171. https://doi.org/10.2174/1381612824666180717105128
Krainer FW, Dietzsch C, Hajek T et al (2012) Recombinant protein expression in Pichia pastoris strains with an engineered methanol utilization pathway. Microb Cell Fact 11:22. https://doi.org/10.1186/1475-2859-11-22
Kumar D, Batra J, Komives C, Rathore A (2019a) QbD based media development for the production of fab fragments in E. coli. Bioengineering 6:29. https://doi.org/10.3390/bioengineering6020029
Kumar D, Batra J, Komives C, Rathore A (2019b) QbD based media development for the production of fab fragments in E. coli. Bioengineering 6:29. https://doi.org/10.3390/bioengineering6020029
Łącki KM, Riske FJ (2020) Affinity chromatography: an enabling technology for large-scale bioprocessing. Biotechnol J 15:1800397. https://doi.org/10.1002/biot.201800397
Lagassé HAD, Alexaki A, Simhadri VL, et al (2017) Recent advances in (therapeutic protein) drug development. F1000Res 6:113. https://doi.org/10.12688/f1000research.9970.1
Lalonde M-E, Durocher Y (2017) Therapeutic glycoprotein production in mammalian cells. J Biotechnol 251:128–140. https://doi.org/10.1016/j.jbiotec.2017.04.028
Larrick JW, Yu L, Naftzger C et al (2001) Production of secretory IgA antibodies in plants. Biomol Eng 18:87–94. https://doi.org/10.1016/S1389-0344(01)00102-2
Leader B, Baca QJ, Golan DE (2008) Protein therapeutics: a summary and pharmacological classification. Nat Rev Drug Discov 7:21–39. https://doi.org/10.1038/nrd2399
Lee JS, Grav LM, Lewis NE, Faustrup Kildegaard H (2015) CRISPR/Cas9-mediated genome engineering of CHO cell factories: application and perspectives. Biotechnol J 10:979–994. https://doi.org/10.1002/biot.201500082
Lee AC-L, Harris JL, Khanna KK, Hong J-H (2019) A Comprehensive review on current advances in peptide drug development and design. Int J Mol Sci 20:2383. https://doi.org/10.3390/ijms20102383
Legastelois I, Buffin S, Peubez I et al (2017) Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules. Hum Vaccin Immunother 13:947–961. https://doi.org/10.1080/21645515.2016.1260795
Levin D, Golding B, Strome SE, Sauna ZE (2015) Fc fusion as a platform technology: potential for modulating immunogenicity. Trends Biotechnol 33:27–34. https://doi.org/10.1016/j.tibtech.2014.11.001
Levin P, Zhou S, Durden E et al (2016) Clinical and economic outcomes associated with the timing of initiation of basal insulin in patients with type 2 diabetes mellitus previously treated with oral antidiabetes drugs. Clin Ther 38:110–121. https://doi.org/10.1016/j.clinthera.2015.11.011
Li SW, Yu B, Byrne G et al (2019) Identification and CRISPR/Cas9 inactivation of the C1s protease responsible for proteolysis of recombinant proteins produced in CHO cells. Biotechnol Bioeng 116:2130–2145. https://doi.org/10.1002/bit.27016
Li SW, Wright M, Healey JF et al (2020) Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: production of HIV envelope proteins as vaccine immunogens. PLoS ONE 15:e0233866. https://doi.org/10.1371/journal.pone.0233866
Lin AY, Dinner SN (2019) Moxetumomab pasudotox for hairy cell leukemia: preclinical development to FDA approval. Blood Adv 3:2905–2910. https://doi.org/10.1182/bloodadvances.2019000507
Lobstein J, Emrich CA, Jeans C et al (2012) SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm. Microb Cell Fact 11:753. https://doi.org/10.1186/1475-2859-11-56
Loh H-S, Green BJ, Yusibov V (2017) Using transgenic plants and modified plant viruses for the development of treatments for human diseases. Curr Opin Virol 26:81–89. https://doi.org/10.1016/j.coviro.2017.07.019
Lomonossoff GP, D’Aoust M-A (2016) Plant-produced biopharmaceuticals: a case of technical developments driving clinical deployment. Science 353:1237–1240. https://doi.org/10.1126/science.aaf6638
Looser V, Bruhlmann B, Bumbak F et al (2015) Cultivation strategies to enhance productivity of Pichia pastoris: a review. Biotechnol Adv 33:1177–1193. https://doi.org/10.1016/j.biotechadv.2015.05.008
Love KR, Dalvie NC, Love JC (2018) The yeast stands alone: the future of protein biologic production. Curr Opin Biotechnol 53:50–58. https://doi.org/10.1016/j.copbio.2017.12.010
Lozano Terol G, Gallego-Jara J, Sola Martínez RA, et al (2019) Engineering protein production by rationally choosing a carbon and nitrogen source using E. coli BL21 acetate metabolism knockout strains. Microb Cell Fact 18:151. https://doi.org/10.1186/s12934-019-1202-1
Luo B, Lee AS (2013) The critical roles of endoplasmic reticulum chaperones and unfolded protein response in tumorigenesis and anticancer therapies. Oncogene 32:805–818. https://doi.org/10.1038/onc.2012.130
MacKenzie IZ, Bichler J, Mason GC et al (2004) Efficacy and safety of a new, chromatographically purified rhesus (D) immunoglobulin. Eur J Obstetr Gynecol Reprod Biol 117:154–161. https://doi.org/10.1016/j.ejogrb.2004.03.009
Macri C, Dumont C, Johnston AP, Mintern JD (2016) Targeting dendritic cells: a promising strategy to improve vaccine effectiveness. Clin Transl Immunology 5:e66. https://doi.org/10.1038/cti.2016.6
Madhavan A, Pandey A, Sukumaran RK (2017) Expression system for heterologous protein expression in the filamentous fungus Aspergillus unguis. Biores Technol 245:1334–1342. https://doi.org/10.1016/j.biortech.2017.05.140
Maksimenko OG, Deykin AV, Khodarovich YM, Georgiev PG (2013) Use of transgenic animals in biotechnology: prospects and problems. Acta Naturae 5:33–46. https://doi.org/10.32607/20758251-2013-5-1-33-46
Maksum IP, Nabiel A, Ishmayana S, Soedjanaatmadja UM (2020) Safety aspect of recombinant protein produced by Escherichia coli: toxin evaluation with strain and genomic approach. In: E. Coli Infections-importance of early diagnosis and efficient treatment. IntechOpen. https://doi.org/10.5772/intechopen.92031
Manna S, Di Natale C, Florio D, Marasco D (2018) Peptides as therapeutic agents for inflammatory-related diseases. Int J Mol Sci 19:2714. https://doi.org/10.3390/ijms19092714
Manuell AL, Beligni MV, Elder JH et al (2007) Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. Plant Biotechnol J 5:402–412. https://doi.org/10.1111/j.1467-7652.2007.00249.x
Martemyanov KA, Shirokov VA, Kurnasov OV et al (2001) Cell-free production of biologically active polypeptides: application to the synthesis of antibacterial peptide cecropin. Protein Expr Purif 21:456–461. https://doi.org/10.1006/prep.2001.1400
Marx V (2005) Watching peptide drugs grow up. Chem Eng News 83:17–24. https://doi.org/10.1021/cen-v083n011.p017
Masuda Y, Tsuda M, Hashikawa‐Muto C, et al (2019) Cation exchange chromatography performed in overloaded mode is effective in removing viruses during the manufacturing of monoclonal antibodies. Biotechnol Prog. https://doi.org/10.1002/btpr.2858
Mattanovich D, Branduardi P, Dato L et al (2012) Recombinant protein production in yeasts. In: Lorence A (ed) Recombinant gene expression. Humana Press, Totowa, pp 329–358
Matthews CB, Wright C, Kuo A et al (2017) Reexamining opportunities for therapeutic protein production in eukaryotic microorganisms. Biotechnol Bioeng 114:2432–2444. https://doi.org/10.1002/bit.26378
Matucci A, Nencini F, Maggi E, Vultaggio A (2019) Hypersensitivity reactions to biologics used in rheumatology. Expert Rev Clin Immunol 15:1263–1271. https://doi.org/10.1080/1744666X.2020.1684264
Mayfield SP, Franklin SE, Lerner RA (2003) Expression and assembly of a fully active antibody in algae. Proc Natl Acad Sci USA 100:438–442. https://doi.org/10.1073/pnas.0237108100
Mazor R, King EM, Onda M et al (2018) Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1717063115
McCarthy DP, Yap JW-T, Harp CT et al (2017) An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy. Nanomedicine 13:191–200. https://doi.org/10.1016/j.nano.2016.09.007
McLaughlin M, Vandenbroeck K (2011) The endoplasmic reticulum protein folding factory and its chaperones: new targets for drug discovery?: ER chaperones as targets in drug discovery. Br J Pharmacol 162:328–345. https://doi.org/10.1111/j.1476-5381.2010.01064.x
Meade E, Hehir S, Rowan N, Garvey M (2022) Mycotherapy: potential of fungal bioactives for the treatment of mental health disorders and morbidities of chronic pain. JoF 8:290. https://doi.org/10.3390/jof8030290
Mengdai X, Xiaoxing M, Hao H et al (2020) Yeast beta-Glucan effects on gut microbiota for regulating insulin signaling system on alzheimer’s disease. Proc Nutr Soc 79(OCE2):E263. https://doi.org/10.1017/s0029665120002116
Merritt JH, Ollis AA, Fisher AC, DeLisa MP (2013) Glycans-by-design: engineering bacteria for the biosynthesis of complex glycans and glycoconjugates. Biotechnol Bioeng 110:1550–1564. https://doi.org/10.1002/bit.24885
Mf P, Va T, Sj C, et al (2021) Single-use systems bioreactors in the biopharmaceutical industry and its use in SARS-CoV-2 candidate vaccine production—a review. Prensa Med Argent. https://doi.org/10.47275/0032-745X-348
Miceli M, Cutignano A, Conte M et al (2019) Monoacylglycerides from the Diatom Skeletonema marinoi induce selective cell death in cancer cells. Mar Drugs 17:625. https://doi.org/10.3390/md17110625
Miguel S, Nisse E, Biteau F et al (2019) Assessing carnivorous plants for the production of recombinant proteins. Front Plant Sci 10:793. https://doi.org/10.3389/fpls.2019.00793
Monteil V, Kwon H, Prado P et al (2020) Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181:905-913.e7. https://doi.org/10.1016/j.cell.2020.04.004
Monzani PS, Adona PR, Ohashi OM et al (2016) Transgenic bovine as bioreactors: challenges and perspectives. Bioengineered 7:123–131. https://doi.org/10.1080/21655979.2016.1171429
Moura RR, Melo LM, Freitas VJDF (2011) Production of recombinant proteins in milk of transgenic and non-transgenic goats. Braz Arch Biol Technol 54:927–938. https://doi.org/10.1590/S1516-89132011000500010
Moustafa K, Makhzoum A, Trémouillaux-Guiller J (2016) Molecular farming on rescue of pharma industry for next generations. Crit Rev Biotechnol 36:840–850. https://doi.org/10.3109/07388551.2015.1049934
Moyade P, Vinjamuri S (2019) The heart matters: a review of incidental cardiac uptake on Ga-68 DOTA peptide PET-CT scans. Nucl Med Commun 40:1081–1085. https://doi.org/10.1097/MNM.0000000000001064
Murashima K, Chen C-L, Kosugi A et al (2002) Heterologous production of clostridium cellulovorans engB, using protease-deficient bacillus subtilis, and preparation of active recombinant cellulosomes. J Bacteriol 184:76–81. https://doi.org/10.1128/JB.184.1.76-81.2002
Nakar C, Shapiro A (2019) Hemophilia A with inhibitor: immune tolerance induction (ITI) in the mirror of time. Transfus Apher Sci 58:578–589. https://doi.org/10.1016/j.transci.2019.08.008
Narayanan H, Sokolov M, Butté A, Morbidelli M (2019) Decision Tree‐PLS (DT‐PLS) algorithm for the development of process: Specific local prediction models. Biotechnol Progr. https://doi.org/10.1002/btpr.2818
Naz Z, Kanwal A, Tayyeb A (2022) A Review on empirical approach to therapeutic recombinant protein production factories: applications, pharmacokinetics and challenges. J Bioresour Manag 9:16
Neville JJ, Orlando J, Mann K et al (2017) Ubiquitous chromatin-opening elements (UCOEs): applications in biomanufacturing and gene therapy. Biotechnol Adv 35:557–564. https://doi.org/10.1016/j.biotechadv.2017.05.004
Nguyen VD, Hatahet F, Salo KE, et al (2011) Pre-expression of a sulfhydryl oxidase significantly increases the yields of eukaryotic disulfide bond containing proteins expressed in the cytoplasm of E.coli. Microb Cell Fact 10:1. https://doi.org/10.1186/1475-2859-10-1
Nielsen J (2013) Production of biopharmaceutical proteins by yeast: advances through metabolic engineering. Bioengineered 4:207–211. https://doi.org/10.4161/bioe.22856
Nishida T, Kubota S, Takigawa M (2017) Production of recombinant CCN2 protein by mammalian cells. In: Takigawa M (ed) CCN Proteins. Springer, New York, pp 95–105
Nunberg JH, Meade JH, Cole G et al (1984) Molecular cloning and characterization of the glucoamylase gene of Aspergillus awamori. Mol Cell Biol 4:2306–2315. https://doi.org/10.1128/mcb.4.11.2306-2315.1984
Oates JA, Wood AJJ, Jankovic J, Brin MF (1991) Therapeutic uses of botulinum toxin. N Engl J Med 324:1186–1194. https://doi.org/10.1056/NEJM199104253241707
Oeller M, Kang RJD, Bolt HL et al (2023) Sequence-based prediction of the intrinsic solubility of peptides containing non-natural amino acids. Nat Commun 14:7475. https://doi.org/10.1038/s41467-023-42940-w
Ohya S, Matsuda T (2005) Poly (N-isopropylacrylamide) (PNIPAM)-grafted gelatin as thermoresponsive three-dimensional artificial extracellular matrix: molecular and formulation parameters vs. cell proliferation potential. J Biomater Sci Polym Ed 16:809–827. https://doi.org/10.1163/1568562054255736
Osz-Papai J, Radu L, Abdulrahman W et al (2015) Insect cells-baculovirus system for the production of difficult to express proteins. In: García-Fruitós E (ed) Insoluble proteins. Springer, New York, pp 181–205
Owczarek B, Gerszberg A, Hnatuszko-Konka K (2019) A brief reminder of systems of production and chromatography-based recovery of recombinant protein biopharmaceuticals. Biomed Res Int 2019:1–13. https://doi.org/10.1155/2019/4216060
Padhi A, Sengupta M, Sengupta S et al (2014) Antimicrobial peptides and proteins in mycobacterial therapy: current status and future prospects. Tuberculosis 94:363–373. https://doi.org/10.1016/j.tube.2014.03.011
Pandhal J, Wright PC (2010) N-Linked glycoengineering for human therapeutic proteins in bacteria. Biotechnol Lett 32:1189–1198. https://doi.org/10.1007/s10529-010-0289-6
Papaneophytou CP, Kontopidis GA (2012) Optimization of TNF-α overexpression in Escherichia coli using response surface methodology: purification of the protein and oligomerization studies. Protein Expr Purif 86:35–44. https://doi.org/10.1016/j.pep.2012.09.002
Paraskevopoulou V, Falcone F (2018) Polyionic tags as enhancers of protein solubility in recombinant protein expression. Microorganisms 6:47. https://doi.org/10.3390/microorganisms6020047
Park KY, Wi SJ (2016) Potential of plants to produce recombinant protein products. J Plant Biol 59:559–568. https://doi.org/10.1007/s12374-016-0482-9
Parsaie Nasab F, Aebi M, Bernhard G, Frey AD (2013) A combined system for engineering glycosylation efficiency and glycan structure in saccharomyces cerevisiae. Appl Environ Microbiol 79:997–1007. https://doi.org/10.1128/AEM.02817-12
Pastan I, Hassan R, FitzGerald DJ, Kreitman RJ (2006) Immunotoxin therapy of cancer. Nat Rev Cancer 6:559–565. https://doi.org/10.1038/nrc1891
Patel SG, Sayers EJ, He L et al (2019) Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines. Sci Rep 9:6298. https://doi.org/10.1038/s41598-019-42456-8
Pathak M, Dutta D, ProfA R (2014) Analytical QbD: development of a native gel electrophoresis method for measurement of monoclonal antibody aggregates. ELECTROPHORESIS. https://doi.org/10.1002/elps.201400055
Pato TP, Souza MCO, Mattos DA et al (2019) Purification of yellow fever virus produced in Vero cells for inactivated vaccine manufacture. Vaccine 37:3214–3220. https://doi.org/10.1016/j.vaccine.2019.04.077
Pearson S, Kietsiriroje N, Ajjan RA (2019) Oral semaglutide in the management of type 2 diabetes: a report on the evidence to date. Diabetes Metab Syndr Obes 12:2515–2529. https://doi.org/10.2147/DMSO.S229802
Penna G, Amuchastegui S, Laverny G, Adorini L (2007) Vitamin D receptor agonists in the treatment of autoimmune diseases: selective targeting of myeloid but not plasmacytoid dendritic cells. J Bone Miner Res 22(Suppl 2):V69-73. https://doi.org/10.1359/jbmr.07s217
Pero J, Sloma A (1993) Proteases. In: Bacillus subtilis and other gram‐positive bacteria: biochemistry, physiology, and molecular genetics, pp 939–952. https://doi.org/10.1128/9781555818388.ch63
Pieters R, Hunger SP, Boos J et al (2011) L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase. Cancer 117:238–249. https://doi.org/10.1002/cncr.25489
Polez S, Origi D, Zahariev S et al (2016) A simplified and efficient process for insulin production in Pichia pastoris. PLoS ONE 11:e0167207. https://doi.org/10.1371/journal.pone.0167207
Potla Durthi C, Pola M, Kola AK, Rajulapati SB (2019) Screening, optimization of culture conditions and scale-up for production of the L-Glutaminase by novel isolated Bacillus sps. mutant endophyte using response surface methodology. Biocatal Agric Biotechnol 18:101077. https://doi.org/10.1016/j.bcab.2019.101077
Qarawi MA, Farah FH, Mohamed SS, El Haj BM (2019) A review on therapeutic proteins: stability aspects and clinical implications. Int Res J Pharm 10:1–7. https://doi.org/10.7897/2230-8407.100233
Raab N, Mathias S, Alt K et al (2019) CRISPR/Cas9-mediated knockout of microRNA-744 improves antibody titer of CHO production cell lines. Biotechnol J 14:1800477. https://doi.org/10.1002/biot.201800477
Rahimi A, Hosseini SN, Karimi A et al (2019) Enhancing the efficiency of recombinant hepatitis B surface antigen production in Pichia pastoris by employing continuous fermentation. Biochem Eng J 141:112–119. https://doi.org/10.1016/j.bej.2018.10.019
Rajendra Y, Balasubramanian S, Peery RB et al (2017) Bioreactor scale up and protein product quality characterization of piggyBac transposon derived CHO pools. Biotechnol Progress 33:534–540. https://doi.org/10.1002/btpr.2447
Ramos-de-la-Peña AM, González-Valdez J, Aguilar O (2019) Protein A chromatography: challenges and progress in the purification of monoclonal antibodies. J Sep Sci 42:1816–1827. https://doi.org/10.1002/jssc.201800963
Rao TSS, Andrade C (2020) Bremelanotide for hypoactive sexual desire disorder. J Psychosex Health 2:13–15. https://doi.org/10.1177/2631831820909450
Rasala BA, Mayfield SP (2015) Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses. Photosynth Res 123:227–239. https://doi.org/10.1007/s11120-014-9994-7
Reddy PH, Johnson AMA, Kumar JK et al (2017) Heterologous expression of Infectious bursal disease virus VP2 gene in Chlorella pyrenoidosa as a model system for molecular farming. Plant Cell Tiss Organ Cult 131:119–126. https://doi.org/10.1007/s11240-017-1268-6
Reinhart D, Damjanovic L, Kaisermayer C et al (2019) Bioprocessing of recombinant CHO-K1, CHO-DG44, and CHO-S: CHO expression hosts favor either mAb production or biomass synthesis. Biotechnol J 14:1700686. https://doi.org/10.1002/biot.201700686
Reyes SJ, Durocher Y, Pham PL, Henry O (2022) Modern sensor tools and techniques for monitoring, controlling, and improving cell culture processes. Processes 10:189. https://doi.org/10.3390/pr10020189
Rita Costa A, Elisa Rodrigues M, Henriques M et al (2010) Guidelines to cell engineering for monoclonal antibody production. Eur J Pharm Biopharm 74:127–138. https://doi.org/10.1016/j.ejpb.2009.10.002
Rizwan M, Mujtaba G, Memon SA et al (2018) Exploring the potential of microalgae for new biotechnology applications and beyond: a review. Renew Sustain Energy Rev 92:394–404. https://doi.org/10.1016/j.rser.2018.04.034
Robinson SD, Safavi-Hemami H, McIntosh LD et al (2014) Diversity of conotoxin gene superfamilies in the venomous snail, conus victoriae. PLOS ONE 9:e87648. https://doi.org/10.1371/journal.pone.0087648
Román R, Miret J, Roura A et al (2019) Enabling HEK293 cells for antibiotic-free media bioprocessing through CRISPR/Cas9 gene editing. Biochem Eng J 151:107299. https://doi.org/10.1016/j.bej.2019.107299
Roth DA, Tawa NE, O’Brien JM et al (2001) Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med 344:1735–1742. https://doi.org/10.1056/NEJM200106073442301
Rozov SM, Deineko EV (2019) Strategies for optimizing recombinant protein synthesis in plant cells: classical approaches and new directions. Mol Biol 53:157–175. https://doi.org/10.1134/S0026893319020146
Rozov SM, Permyakova NV, Deineko EV (2018) Main strategies of plant expression system glycoengineering for producing humanized recombinant pharmaceutical proteins. Biochemistry Moscow 83:215–232. https://doi.org/10.1134/S0006297918030033
Rutgers T, Gordon D, Gathoye AM et al (1988) Hepatitis B surface antigen as carrier matrix for the repetitive epitope of the circumsporozoite protein of plasmodium falciparum. Nat Biotechnol 6:1065–1070. https://doi.org/10.1038/nbt0988-1065
Sagiya Y, Yamagata H, Udaka S (1994) Direct high-level secretion into the culture medium of tuna growth hormone in biologically active form by Bacillus brevis. Appl Microbiol Biotechnol 42:358–363
Sakuma T, Takenaga M, Kawabe Y et al (2015) Homologous recombination-independent large gene cassette knock-in in CHO cells using TALEN and MMEJ-directed donor plasmids. IJMS 16:23849–23866. https://doi.org/10.3390/ijms161023849
Salazar-Fontana LI, Desai DD, Khan TA et al (2017) Approaches to mitigate the unwanted immunogenicity of therapeutic proteins during drug development. AAPS J 19:377–385. https://doi.org/10.1208/s12248-016-0030-z
Saltz LB, Meropol NJ, Loehrer PJ et al (2004) Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. JCO 22:1201–1208. https://doi.org/10.1200/JCO.2004.10.182
Saraswat M, Musante L, Ravidá A et al (2013) Preparative purification of recombinant proteins: current status and future trends. Biomed Res Int 2013:1–18. https://doi.org/10.1155/2013/312709
Saraya R, Gidijala L, Veenhuis M, Van Der Klei IJ (2014) Tools for genetic engineering of the yeast hansenula polymorpha. In: Mapelli V (ed) Yeast Metabolic Engineering. Springer, New York, New York, NY, pp 43–62
Sato D, Nozaki T (2009) Methionine gamma-lyase: the unique reaction mechanism, physiological roles, and therapeutic applications against infectious diseases and cancers. IUBMB Life 61:1019–1028. https://doi.org/10.1002/iub.255
Saul D, Sudbery P (1985) Molecular cloning of WHI2, a gene involved in the regulation of cell proliferation in Saccharomyces cerevisiae. Microbiology 131:1797–1806
Sauna ZE, Lagassé D, Pedras-Vasconcelos J et al (2018) Evaluating and mitigating the immunogenicity of therapeutic proteins. Trends Biotechnol 36:1068–1084. https://doi.org/10.1016/j.tibtech.2018.05.008
Sawatzki A, Hans S, Narayanan H et al (2018) Accelerated bioprocess development of endopolygalacturonase-production with saccharomyces cerevisiae using multivariate prediction in a 48 mini-bioreactor automated platform. Bioengineering 5:101. https://doi.org/10.3390/bioengineering5040101
Schillberg S, Raven N, Spiegel H et al (2019) Critical analysis of the commercial potential of plants for the production of recombinant proteins. Front Plant Sci 10:720. https://doi.org/10.3389/fpls.2019.00720
Schmidt SR (2022) Process intensification based on disposable solutions as first step toward continuous processing. In: Subramanian G (ed) Process control, intensification, and digitalisation in continuous biomanufacturing, 1st edn. Wiley, pp 137–178
Schmuck B, Chen G, Pelcman J, et al (2021) Expression of the human molecular chaperone domain Bri2 BRICHOS on a gram per liter scale with an E. coli fed-batch culture. Microb Cell Fact 20:150. https://doi.org/10.1186/s12934-021-01638-8
Seo H-S, Park J-S, Han K-Y et al (2008) Analysis and characterization of hepatitis B vaccine particles synthesized from Hansenula polymorpha. Vaccine 26:4138–4144. https://doi.org/10.1016/j.vaccine.2008.05.070
Seyis I, Aksoz N (2005) Effect of carbon and nitrogen sources on xylanase production by Trichoderma harzianum 1073 D3. Int Biodeterior Biodegrad 55:115–119. https://doi.org/10.1016/j.ibiod.2004.09.001
Shaikh R, O’Brien DP, Croker DM, Walker GM (2018) The development of a pharmaceutical oral solid dosage forms. In: Computer aided chemical engineering. Elsevier, New York, pp 27–65
Shankar R, Upadhyay PK, Kumar M (2021) Protease enzymes: highlights on potential of proteases as therapeutics agents. Int J Pept Res Ther 27:1281–1296. https://doi.org/10.1007/s10989-021-10167-2
Sharker SMd, Rahman A (2021) A review on the current methods of chinese hamster ovary (CHO) cells cultivation for the production of therapeutic protein. CDDT 18:354–364. https://doi.org/10.2174/1570163817666200312102137
Sharma A, Herekar AA, Bhagatwala J, Rao SS (2019) Profile of plecanatide in the treatment of chronic idiopathic constipation: design, development, and place in therapy. Clin Exp Gastroenterol 12:31–36. https://doi.org/10.2147/CEG.S145668
Shekhawat LK, Godara A, Kumar V, Rathore AS (2019) Design of experiments applications in bioprocessing: chromatography process development using split design of experiments. Biotechnol Prog 35:e2730. https://doi.org/10.1002/btpr.2730
Shepelev MV, Kalinichenko SV, Deykin AV, Korobko IV (2018) Production of recombinant proteins in the milk of transgenic animals: current state and prospects. Acta Naturae 10:40–47. https://doi.org/10.32607/20758251-2018-10-3-40-47
Shih HH (2012) Discovery process for antibody-based therapeutics. In: Tabrizi MA, Bornstein GG, Klakamp SL (eds) Development of antibody-based therapeutics. Springer, New York, pp 9–32
Shrivastava A, Pal M, Sharma RK (2023) Pichia as yeast cell factory for production of industrially important bio-products: Current trends, challenges, and future prospects. J Bioresour Bioprod 8:108–124. https://doi.org/10.1016/j.jobab.2023.01.007
Shukla AA, Thömmes J (2010) Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol 28:253–261. https://doi.org/10.1016/j.tibtech.2010.02.001
Slattery SS, Giguere DJ, Stuckless EE et al (2022) Phosphate-regulated expression of the SARS-CoV-2 receptor-binding domain in the diatom Phaeodactylum tricornutum for pandemic diagnostics. Sci Rep 12:7010. https://doi.org/10.1038/s41598-022-11053-7
Sodee DB, Malguria N, Faulhaber P et al (2000) Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. Urology 56:988–993. https://doi.org/10.1016/S0090-4295(00)00824-4
Solá RJ, Griebenow K (2010) Glycosylation of therapeutic proteins: an effective strategy to optimize efficacy. BioDrugs 24:9–21. https://doi.org/10.2165/11530550-000000000-00000
Soria-Guerra RE, Ramírez-Alonso JI, Ibáñez-Salazar A et al (2014) Expression of an HBcAg-based antigen carrying angiotensin II in Chlamydomonas reinhardtii as a candidate hypertension vaccine. Plant Cell Tiss Organ Cult 116:133–139. https://doi.org/10.1007/s11240-013-0388-x
Specht EA, Mayfield SP (2014) Algae-based oral recombinant vaccines. Front Microbiol 5:76662. https://doi.org/10.3389/fmicb.2014.00060
Sproles AE, Fields FJ, Smalley TN et al (2021) Recent advancements in the genetic engineering of microalgae. Algal Res 53:102158. https://doi.org/10.1016/j.algal.2020.102158
Stebbings R, Poole S, Thorpe R (2009) Safety of biologics, lessons learnt from TGN1412. Curr Opin Biotechnol 20:673–677. https://doi.org/10.1016/j.copbio.2009.10.002
Svahn KS, Chryssanthou E, Olsen B et al (2015) Penicillium nalgiovense Laxa isolated from Antarctica is a new source of the antifungal metabolite amphotericin B. Fungal Biol Biotechnol 2:1. https://doi.org/10.1186/s40694-014-0011-x
Tai W, He L, Zhang X et al (2020) Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Cell Mol Immunol 17:613–620. https://doi.org/10.1038/s41423-020-0400-4
Talukdar J, Dasgupta S, Nagle V, Bhadra B (2020) COVID-19: potential of microalgae derived natural astaxanthin as adjunctive supplement in alleviating cytokine storm. SSRN J. https://doi.org/10.2139/ssrn.3579738
Tang H, Wang S, Wang J et al (2016) N-hypermannose glycosylation disruption enhances recombinant protein production by regulating secretory pathway and cell wall integrity in Saccharomyces cerevisiae. Sci Rep 6:25654. https://doi.org/10.1038/srep25654
Tekoah Y, Shulman A, Kizhner T et al (2015) Large-scale production of pharmaceutical proteins in plant cell culture-the protalix experience. Plant Biotechnol J 13:1199–1208. https://doi.org/10.1111/pbi.12428
Terpe K (2006) Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 72:211–222. https://doi.org/10.1007/s00253-006-0465-8
Tesfaw A, Assefa F (2014) Current trends in bioethanol production by Saccharomyces cerevisiae : substrate, inhibitor reduction, growth variables, coculture, and immobilization. Int Scholarly Res Notices 2014:1–11. https://doi.org/10.1155/2014/532852
Tie Y, Tang F, Wei Y, Wei X (2022) Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets. J Hematol Oncol 15:61. https://doi.org/10.1186/s13045-022-01282-8
Tihanyi B, Nyitray L (2020) Recent advances in CHO cell line development for recombinant protein production. Drug Discov Today Technol 38:25–34. https://doi.org/10.1016/j.ddtec.2021.02.003
Ton C, Stabile V, Carey E et al (2023) Development and scale-up of rVSV-SARS-CoV-2 vaccine process using single use bioreactor. Biotechnol Rep 37:e00782. https://doi.org/10.1016/j.btre.2023.e00782
Tong P, Hong Y, Xiao Y et al (2007) High production of laccase by a new basidiomycete, Trametes sp. Biotechnol Lett 29:295–301. https://doi.org/10.1007/s10529-006-9241-1
De La Torre BG, Albericio F (2020) Peptide therapeutics 2.0. Molecules 25:2293. https://doi.org/10.3390/molecules25102293
Tran M, Zhou B, Pettersson PL et al (2009) Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts. Biotechnol Bioeng. https://doi.org/10.1002/bit.22446
Tran M, Van C, Barrera DJ et al (2013) Production of unique immunotoxin cancer therapeutics in algal chloroplasts. Proc Natl Acad Sci USA. https://doi.org/10.1073/pnas.1214638110
Trassaert M, Vandermies M, Carly F et al (2017) New inducible promoter for gene expression and synthetic biology in Yarrowia lipolytica. Microb Cell Fact 16:141. https://doi.org/10.1186/s12934-017-0755-0
Tripathi NK, Shrivastava A (2019) Recent developments in bioprocessing of recombinant proteins: expression hosts and process development. Front Bioeng Biotechnol 7:420. https://doi.org/10.3389/fbioe.2019.00420
Tsomaia N (2015) Peptide therapeutics: targeting the undruggable space. Eur J Med Chem 94:459–470. https://doi.org/10.1016/j.ejmech.2015.01.014
Turki S, Mrabet G, Jabloun Z et al (2010) A highly stable Yarrowia lipolytica lipase formulation for the treatment of pancreatic exocrine insufficiency. Biotechnol Appl Biochem 57:139–149. https://doi.org/10.1042/BA20100272
Udaka S, Yamagata H (2020) Extremely efficient protein secretion system in Bacillus brewis. Recombinant Microbes for Industrial and Agricultural Applications 71–79
Unni S, Prabhu AA, Pandey R et al (2019) Artificial neural network-genetic algorithm (ANN-GA) based medium optimization for the production of human interferon gamma (hIFN-γ) in Kluyveromyces lactis cell factory. Can J Chem Eng 97:843–858. https://doi.org/10.1002/cjce.23350
Utomo JC, Hodgins CL, Ro D-K (2021) Multiplex genome editing in yeast by CRISPR/Cas9—a potent and agile tool to reconstruct complex metabolic pathways. Front Plant Sci 12:719148. https://doi.org/10.3389/fpls.2021.719148
Valderrama-Rincon JD, Fisher AC, Merritt JH et al (2012) An engineered eukaryotic protein glycosylation pathway in Escherichia coli. Nat Chem Biol 8:434–436. https://doi.org/10.1038/nchembio.921
Van Roy M, Ververken C, Beirnaert E et al (2015) The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis. Arthritis Res Ther 17:135. https://doi.org/10.1186/s13075-015-0651-0
van Zonneveld M, Honkoop P, Hansen BE et al (2004) Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B. Hepatology 39:804–810. https://doi.org/10.1002/hep.20128
Vandermies M, Fickers P (2019) Bioreactor-scale strategies for the production of recombinant protein in the yeast Yarrowia lipolytica. Microorganisms 7:40. https://doi.org/10.3390/microorganisms7020040
Vanier G, Hempel F, Chan P et al (2015) Biochemical Characterization of human anti-hepatitis B monoclonal antibody produced in the microalgae Phaeodactylum tricornutum. PLoS ONE 10:e0139282. https://doi.org/10.1371/journal.pone.0139282
Varki A (2017) Biological roles of glycans. Glycobiology 27:3–49. https://doi.org/10.1093/glycob/cww086
Verhoef JJF, Carpenter JF, Anchordoquy TJ, Schellekens H (2014) Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics. Drug Discovery Today 19:1945–1952. https://doi.org/10.1016/j.drudis.2014.08.015
Vieira Gomes A, Souza Carmo T, Silva Carvalho L et al (2018) Comparison of yeasts as hosts for recombinant protein production. Microorganisms 6:38. https://doi.org/10.3390/microorganisms6020038
Walsh G (2010) Biopharmaceutical benchmarks 2010. Nat Biotechnol 28:917–924. https://doi.org/10.1038/nbt0910-917
Walsh G (2018) Biopharmaceutical benchmarks 2018. Nat Biotechnol 36:1136–1145. https://doi.org/10.1038/nbt.4305
Wang P, Sidney J, Dow C et al (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 4:e1000048. https://doi.org/10.1371/journal.pcbi.1000048
Wang Y, Zhao S, Bai L et al (2013) Expression systems and species used for transgenic animal bioreactors. Biomed Res Int 2013:1–9. https://doi.org/10.1155/2013/580463
Wang H, Chen X, Huang Z et al (2014) Expression and purification of porcine PID1 gene in Escherichia coli. Turk J Biol 38:523–527. https://doi.org/10.3906/biy-1403-38
Wang G, Huang M, Nielsen J (2017) Exploring the potential of Saccharomyces cerevisiae for biopharmaceutical protein production. Curr Opin Biotechnol 48:77–84. https://doi.org/10.1016/j.copbio.2017.03.017
Wang R, Pan W, Jin L et al (2020) Human papillomavirus vaccine against cervical cancer: opportunity and challenge. Cancer Lett 471:88–102. https://doi.org/10.1016/j.canlet.2019.11.039
Wang L, Wang N, Zhang W et al (2022) Therapeutic peptides: current applications and future directions. Sig Transduct Target Ther 7:48. https://doi.org/10.1038/s41392-022-00904-4
Wannathong T, Waterhouse JC, Young REB et al (2016) New tools for chloroplast genetic engineering allow the synthesis of human growth hormone in the green alga Chlamydomonas reinhardtii. Appl Microbiol Biotechnol 100:5467–5477. https://doi.org/10.1007/s00253-016-7354-6
Ward M, Lin C, Victoria DC et al (2004) Characterization of humanized antibodies secreted by Aspergillus niger. Appl Environ Microbiol 70:2567–2576. https://doi.org/10.1128/AEM.70.5.2567-2576.2004
Weesner JA, Annunziata I, Yang T et al (2022) Preclinical enzyme replacement therapy with a recombinant β-galactosidase-lectin fusion for CNS delivery and treatment of GM1-gangliosidosis. Cells 11:2579. https://doi.org/10.3390/cells11162579
Weigel T, Soliman R, Wolff MW, Reichl U (2019) Hydrophobic-interaction chromatography for purification of influenza A and B virus. J Chromatogr B 1117:103–117. https://doi.org/10.1016/j.jchromb.2019.03.037
Werten MWT, Eggink G, Cohen Stuart MA, de Wolf FA (2019) Production of protein-based polymers in Pichia pastoris. Biotechnol Adv 37:642–666. https://doi.org/10.1016/j.biotechadv.2019.03.012
Wilken LR, Nikolov ZL (2012) Recovery and purification of plant-made recombinant proteins. Biotechnol Adv 30:419–433. https://doi.org/10.1016/j.biotechadv.2011.07.020
Witmer C, Young G (2013) Factor VIII inhibitors in hemophilia A: rationale and latest evidence. Ther Adv Hematol 4:59–72. https://doi.org/10.1177/2040620712464509
Witzig TE, Gordon LI, Cabanillas F et al (2002) Randomized controlled trial of yttrium-90–labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed b-cell non-hodgkin’s lymphoma. JCO 20:2453–2463. https://doi.org/10.1200/JCO.2002.11.076
Xiang Z-X, Gong J-S, Shi J-H et al (2022) High-efficiency secretory expression and characterization of the recombinant type III human-like collagen in Pichia pastoris. Bioresour Bioprocess 9:117. https://doi.org/10.1186/s40643-022-00605-4
Xu J, Towler M, Weathers PJ (2016) Platforms for plant-based protein production. In: Pavlov A, Bley T (eds) Bioprocessing of plant in vitro systems. Springer International Publishing, Cham, pp 1–40
Xu L, Chen B, Geng X et al (2019) A protease-resistant α-galactosidase characterized by relatively acid pH tolerance from the Shitake Mushroom Lentinula edodes. Int J Biol Macromol 128:324–330. https://doi.org/10.1016/j.ijbiomac.2019.01.051
Yang Z, Zhang Z (2018) Engineering strategies for enhanced production of protein and bio-products in Pichia pastoris: a review. Biotechnol Adv 36:182–195. https://doi.org/10.1016/j.biotechadv.2017.11.002
Yang S, Kuang Y, Li H et al (2013) Enhanced production of recombinant secretory proteins in Pichia pastoris by optimizing Kex2 P1’ site. PLoS ONE 8:e75347. https://doi.org/10.1371/journal.pone.0075347
Yang H, Wang J, Zhao M et al (2019) Feasible development of stable HEK293 clones by CRISPR/Cas9-mediated site-specific integration for biopharmaceuticals production. Biotechnol Lett 41:941–950. https://doi.org/10.1007/s10529-019-02702-5
Yao J, Weng Y, Dickey A, Wang K (2015) Plants as factories for human pharmaceuticals: applications and challenges. IJMS 16:28549–28565. https://doi.org/10.3390/ijms161226122
YaPing W, Ben R, Ling Z, Lixin M (2017) High-level expression of two thermophilic β-mannanases in Yarrowialipolytica. Protein Expr Purif 133:1–7. https://doi.org/10.1016/j.pep.2017.02.008
Yu LX, Amidon G, Khan MA et al (2014) Understanding pharmaceutical quality by design. AAPS J 16:771–783. https://doi.org/10.1208/s12248-014-9598-3
Yuen KCJ, Johannsson G, Ho KKY, et al (2023) Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis. Endocrine Connect. https://doi.org/10.1530/EC-22-0504
Zeng F, Yang C, Gao X et al (2018) Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment. J Biol Chem 293:19127–19135. https://doi.org/10.1074/jbc.RA118.005367
Zhang J, Lan N (2018) Hirudin variants production by genetic engineered microbial factory. Biotechnol Genet Eng Rev 34:261–280. https://doi.org/10.1080/02648725.2018.1506898
Zhao M, Vandersluis M, Stout J et al (2019) Affinity chromatography for vaccines manufacturing: finally ready for prime time? Vaccine 37:5491–5503. https://doi.org/10.1016/j.vaccine.2018.02.090
Zhou G, Chen S, Chen Z (2020) Advances in COVID-19: the virus, the pathogenesis, and evidence-based control and therapeutic strategies. Front Med 14:117–125. https://doi.org/10.1007/s11684-020-0773-x
Zhu J (2012) Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv 30:1158–1170. https://doi.org/10.1016/j.biotechadv.2011.08.022
Zhu MM, Mollet M, Hubert RS et al (2017) Industrial production of therapeutic proteins: cell lines, cell culture, and purification. In: Kent JA, Bommaraju TV, Barnicki SD (eds) Handbook of industrial chemistry and biotechnology. Springer International Publishing, Cham, pp 1639–1669
Zhu W, Xu R, Gong G et al (2021) Medium optimization for high yield production of human serum albumin in Pichia pastoris and its efficient purification. Protein Expr Purif 181:105831. https://doi.org/10.1016/j.pep.2021.105831
Zhuang H, Hao H, Qiu Y, Gan J, Li T (2023) Recent advances in glycopeptide and glycoprotein synthesis: a refined synthetic probe towards the biological world. Chinese J Chem 41:2010–2024. https://doi.org/10.1002/cjoc.202300035
Zinsli LV, Stierlin N, Loessner MJ, Schmelcher M (2021) Deimmunization of protein therapeutics—recent advances in experimental and computational epitope prediction and deletion. Comput Struct Biotechnol J 19:315–329. https://doi.org/10.1016/j.csbj.2020.12.024
Zydney AL (2016) Continuous downstream processing for high value biological products: a review: continuous downstream processing. Biotechnol Bioeng 113:465–475. https://doi.org/10.1002/bit.25695
Acknowledgements
The authors acknowledge Chandigarh University, Gharuan for providing infrastructure support to conduct the research work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kumar, V., Barwal, A., Sharma, N. et al. Therapeutic proteins: developments, progress, challenges, and future perspectives. 3 Biotech 14, 112 (2024). https://doi.org/10.1007/s13205-024-03958-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-024-03958-z